PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 21, 2026Physics in Medicine and Biology0 citationsOpen Access

Development and characterisation of a radiobiology proton beamline using radiochromic film dosimetry

View Full Paper
CCCarina Marques CoelhoPFPablo de la Fuente FernándezPBP. Bononad Bononad

Key Points

  • To develop and optimise a low-energy proton beamline for radiobiological applications at CMAM.
  • Implemented automated irradiation system with Gafchromic EBT3 film dosimetry.
  • Performed dosimetric calibration using multichannel analysis.
  • Evaluated beam performance based on distance, scanning area, and intensity.
  • Identified optimal conditions at beam currents ≤ 1 nA and 40 × 40 to 50 × 50 mm² scanning areas.
  • Achieved dose distributions with better than 8% reproducibility.
  • Demonstrated linearity across clinically relevant dose ranges and effective proton exposures in U-87MG glioblastoma cells.

Abstract

To develop and optimise a dedicated low-energy proton beamline at the Centre for Micro-Analysis of Materials (CMAM, Madrid, Spain) for radiobiological applications. Approach: An automated irradiation system was implemented, integrating Gafchromic EBT3 radiochromic film (RCF) dosimetry corrected for linear energy transfer (LET) dependent quenching and post-irradiation darkening. Dosimetric calibration was performed using multichannel analysis, and beam performance was systematically evaluated as a function of distance, raster scanning area, beam intensity and reproducibility. Main results: Optimal operating conditions were identified at moderate beam currents (≤ 1 nA) and scanning areas of 40 × 40 to 50 × 50 mm2, yielding homogeneous dose distributions with reproducibility better than 8%. The dosimetric protocol demonstrated linearity across clinically relevant dose ranges and allowed a reliable correlation between irradiation parameters and absorbed dose. Proof-of-concept experiments on U-87MG glioblastoma cells confirmed the system's ability to deliver controlled and biologically effective proton exposures, as demonstrated by clonogenic survival assays. Significance: These results establish the CMAM beamline as a robust and versatile platform for preclinical proton radiobiology, providing accurate dosimetric control and supporting investigations of relative biological efficacy (RBE). The system facilitates translational advances in proton radiobiology, bridging physical and biological studies in low-energy proton irradiation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Coelho et al. (2026) studied this question.

synapsesocial.com/papers/69be35d76e48c4981c6744aehttps://doi.org/10.1088/1361-6560/ae5457
Ask AI
Helpful
Bookmark
Share
View Full Paper